Group One Trading’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Group One Trading’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-41,083	Closed	-$1.06M	–	5515
2017 Q1	$1.09M	Buy	41,083 +35,381	+621%	+$876K	0.01%	1290
2016 Q4	$127K	Buy	5,702 +1,180	+26%	+$22.1K	﹤0.01%	2706
2016 Q3	$84K	Sell	4,522 -200	-4%	-$3.47K	﹤0.01%	3047
2016 Q2	$77K	Sell	4,722 -3,400	-42%	-$57.3K	﹤0.01%	3041
2016 Q1	$115K	Buy	8,122 +6,960	+599%	+$94K	﹤0.01%	2734
2015 Q4	$20K	Buy	+1,162	New	+$22.6K	﹤0.01%	3931

Other funds holding NDRM

VOAM

Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Group One Trading's NDRM Position: Q2 2017 in Review

Group One Trading sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q2 2017, closing a stake of 41,083 shares — an estimated $1.06M sold.

Group One Trading first reported a position in NDRM in Q4 2015 and held it in 6 quarters. The position peaked at $1.09M in Q1 2017. 73 funds tracked by Wall St. Rank hold NDRM as of Q2 2017.

Group One Trading reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q2 2017 after selling out during the quarter.
Group One Trading sold 41,083 NeuroDerm Ltd. Ordinary Shares shares in Q2 2017, an estimated $1.06M.
Group One Trading first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2015 and held it in 6 quarters.
Group One Trading's NeuroDerm Ltd. Ordinary Shares position peaked at $1.09M in Q1 2017.
73 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q2 2017.

Based on Group One Trading's 13F filing for Q2 2017, filed 14 Aug 2017.